NXSTAGE MEDICAL INC - COMMON STOCK (NXTM)

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / COMMON STOCK
Symbol
NXTM
Price per share
$30.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1
Total reported value
$30
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NXSTAGE MEDICAL INC - COMMON STOCK (NXTM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 1 $30 3,000% 1
2025 Q2 1 $30 3,000% 1
2025 Q1 1 $30 3,000% 1
2024 Q4 1 $30 3,000% 1
2024 Q3 1 $30 3,000% 1
2024 Q2 1 $30 3,000% 1
2024 Q1 1 $30 3,000% 1
2023 Q4 1 $30 3,000% 1
2023 Q3 1 $30 3,000% 1
2023 Q2 1 $30 3,000% 1
2023 Q1 1 $30 3,000% 1
2022 Q4 1 $30 +$30 3,000% 1
2020 Q3 0 $0 -$48,000 0
2020 Q2 1,969 $48,000 2,437.79% 1
2019 Q2 0 $0 -$112,366,000 0
2019 Q1 3,926,141 $112,366,000 -$1,634,544,302 2,862% 1
2018 Q4 61,168,210 $1,750,626,793 +$66,861,780 2,862% 168
2018 Q3 58,856,787 $1,641,517,015 +$52,731,632 2,789% 173
2018 Q2 57,062,490 $1,592,309,025 +$111,632 2,790% 169
2018 Q1 57,304,287 $1,424,581,255 -$12,664,946 2,485.97% 166
2017 Q4 57,601,077 $1,395,757,679 -$58,799,639 2,423% 174
2017 Q3 58,635,958 $1,618,326,442 -$40,125,148 2,760% 164
2017 Q2 61,712,331 $1,547,019,598 -$23,037,386 2,506.99% 159
2017 Q1 62,424,108 $1,675,455,841 +$148,052,031 2,682.99% 168
2016 Q4 61,347,615 $1,607,768,791 -$69,137,528 2,620.99% 169
2016 Q3 63,948,823 $1,597,274,461 +$68,235,277 2,499% 153
2016 Q2 62,575,160 $1,356,637,221 +$58,126,080 2,167.98% 143
2016 Q1 61,643,101 $924,003,795 +$19,962,929 1,498.99% 138
2015 Q4 59,630,079 $1,306,455,680 -$28,471,446 2,190.94% 136
2015 Q3 59,935,304 $945,158,694 +$3,488,633 1,576.99% 124
2015 Q2 59,058,993 $843,619,594 +$15,469,292 1,428.5% 137
2015 Q1 57,526,439 $995,373,720 +$26,042,060 1,730% 122
2014 Q4 56,012,295 $1,004,395,244 +$25,823,810 1,793.01% 118
2014 Q3 54,934,216 $721,290,842 +$13,342,627 1,313.01% 110
2014 Q2 53,760,555 $771,663,413 -$36,921,012 1,437% 114
2014 Q1 55,091,439 $701,831,084 +$17,325,458 1,274% 114